Form 4: LanzaTech Global Executive Zarath Summers Reports Stock Option and RSU Grants

Zarath Summers, Chief Science Officer of LanzaTech Global, Inc., reports the acquisition of stock options and restricted stock units (RSUs) on April 5, 2024.

Summary

• On April 5, 2024, Zarath Summers, the Chief Science Officer of LanzaTech Global, Inc., acquired stock options for 162,601 shares and 64,935 restricted stock units (RSUs).
• The stock options have an exercise price of $3.10 and expire on April 5, 2034.
• Both the stock options and RSUs vest in approximately three equal annual installments, starting on March 6, 2025.
• Each RSU represents a contingent right to receive one share of LanzaTech Global, Inc. common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.

Positives

• The grant of stock options and RSUs to the Chief Science Officer aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedule of the stock options and RSUs suggests a continued commitment from the Chief Science Officer to the company's long-term success.

Industry Context

Stock option and RSU grants are a common practice in the technology and biotech industries to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like LanzaTech's.
• Vesting schedules, such as the three-year annual installment plan, are typical to ensure long-term alignment between executive performance and shareholder value.
• Comparing the size of the grant to similar companies in the renewable energy or biotechnology sectors would provide further context on its competitiveness.

Stakeholder Impact

• Shareholders may view the stock option and RSU grants positively, as they incentivize management to increase shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates